Sartorius Stedim Biotech S.A. (France) and Thermo Fisher Scientific (US) are Leading Players in the Single use Bioprocessing Market
The global single-use bioprocessing market is expected to reach USD 20.8 billion by 2026 from USD 8.2 billion in 2021, at a CAGR of 20.5% during the forecast period. The growth in this market is attributed to the increasing demand for low-cost biopharmaceuticals, as single-use bioprocessing systems play a significant role in reducing the initial investments and R&D costs involved in the manufacturing process of biologics. Moreover, the deployment of single-use bioprocessing systems increases the productivity of manufacturing processes as a result of reductions in cost and complexity of automation, and elimination of the need for change-over cleaning/validation between consecutive operations. However, issues such as plastic waste, extractability and leachability of the materials used in bioprocessing are expected to restrict the growth of this market.
The single-use bioprocessing market is highly consolidated with majority of the market share taken up by key players such as Thermo Fisher Scientific (US), Danaher Corporation (US), Sartorius Stedim Biotech S.A. (France), and Merck KGaA (Germany). The key players in this market are increasingly focusing on strategic expansions, partnerships, and product approvals to expand their manufacturing capabilities and increase market presence.
To know about the assumptions considered for the study download the pdf brochure
Sartorius Stedim Biotech held the leading position in the single-use bioprocessing market in 2020. Sartorius focuses on strengthening its position in the market by adopting organic and inorganic strategies such as product launches and expansions. During the past three years, Sartorius Stedim Biotech launched SUB systems such as BIOSTAT STR Generation 3 Single-Use Bioreactor, BIOSTAT RM TX Single-Use Bioreactor, and BIOSTAT STR. In 2019, Sartorius acquired Danaher’s Life Science portfolio, which is complementary to the portfolio of Sartorius’s laboratory and bioprocess business. In 2019, the company also expanded their operations in Puerto Rico.
Thermo Fisher Scientific is the second-largest player in the single-use bioprocessing market. Thermo Fisher Scientific operates in the single-use bioprocessing market through the life science solutions business segment. To further increase its share in the single-use bioprocessing market, the company focuses on growth strategies such as acquisitions and expansion. From 2019 to 2021, the company expanded its business in the US. The company also made investments worth ~USD 650 million from 2019 to 2021 to enhance their single-use bioprocessing capabilities and increase their market share.
Related Reports:
Single use Bioprocessing Market by Product (Media Bags and containers, Bioreactors, Mixers, Assemblies), Application (Cell Culture, Mixing, Storage, Filtration, Purification), End User (Biopharma Companies, CROs, CMOs) - Global Forecast 2026
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
